临床试验

MagDI Canada Study

NCT：NCT06467955 · ACTIVE_NOT_RECRUITING

NCT编号NCT06467955

状态ACTIVE_NOT_RECRUITING

开始日期2024-05-10

SponsorGT Metabolic Solutions, Inc. (INDUSTRY)

First posted2024-06-21

Last updated2026-05-20

简要摘要

The objective of the MagDI Canada study is to evaluate the performance and safety of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion as one example of a small bowel clinical procedure requiring a side-to-side anastomosis. The secondary objective includes initial efficacy of the duodeno-ileal diversion using the MagDI System.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。